TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18926128

Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 99

Group type: COMPARATOR
Intervention: 2003 American Diabetes Association recommended diet
Number of subjects: 99
Study: 15827700

Group type: EXPERIMENTAL
Intervention: Finite Element Method
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dentofacial Planner Plus
Number of subjects: 12
Study: 12585188

Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii polyglycoside (TWP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bimolani (control)
Number of subjects: 100
Study: 10512206

Group type: COMPARATOR
Intervention: Hypoxia (F(I)O2 0.155)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normoxia (F(I)O2 0.209)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Hyperoxia (F(I)O2 0.293)
Number of subjects: 6
Study: 7577284

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 22
Study: 8150760

Group type: EXPERIMENTAL
Intervention: Cefepime 1 g bd
Number of subjects: 131

Group type: COMPARATOR
Intervention: Ceftazidime 1 g tds
Number of subjects: 131
Study: 3529375

Group type: EXPERIMENTAL
Intervention: Weekly low-dose methotrexate (Mtx)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31502272

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (parenteral plus enteral; total 400 mg/kg/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isonitrogenous control
Number of subjects: 60
Study: 29287668

Group type: EXPERIMENTAL
Intervention: Treatment of Integrated Posttraumatic Stress and Substance Use (TIPSS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard cognitive-behavioral treatment (CBT) for SUD
Number of subjects: 0
Study: 28459509

Group type: EXPERIMENTAL
Intervention: Basic Traditional Chinese Diet (BCTD)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Western Standard Diet (WSD)
Number of subjects: 284
Study: 26341920

Group type: EXPERIMENTAL
Intervention: Panitumumab plus FOLFIRI
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 0
Study: 23731573

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (6000 mg iv one hour before contrast CT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 120
Study: 21439551

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group intervention
Number of subjects: 253

Group type: COMPARATOR
Intervention: Bibliotherapy
Number of subjects: 253

Group type: COMPARATOR
Intervention: Educational brochure control
Number of subjects: 253
Study: 20071890

Group type: EXPERIMENTAL
Intervention: Educational program for caregivers
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 38
Study: 16983477

Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior 90 degrees partial fundoplication
Number of subjects: 112

Group type: COMPARATOR
Intervention: Nissen fundoplication
Number of subjects: 112
Study: 15274868

Group type: EXPERIMENTAL
Intervention: Radiometer's Pico 70
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: SIMS-Portex's Pro‐Vent
Number of subjects: 160

Group type: COMPARATOR
Intervention: Becton Dickinson's Preset
Number of subjects: 160

Group type: COMPARATOR
Intervention: SIMS-Concord's Pulsator
Number of subjects: 160

Group type: COMPARATOR
Intervention: Marquest's Quick ABG
Number of subjects: 160

Group type: COMPARATOR
Intervention: Delay of 30 minutes
Number of subjects: 160

Group type: COMPARATOR
Intervention: Delay of 60 minutes
Number of subjects: 160
Study: 11546967

Group type: EXPERIMENTAL
Intervention: Transtracheal open ventilation (TOV)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV) at 10 cm H2O
Number of subjects: 11

Group type: COMPARATOR
Intervention: Open minitracheotomy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Transtracheal gas insufflation
Number of subjects: 11
Study: 9697781

Group type: EXPERIMENTAL
Intervention: Finasteride (n = 1524)
Number of subjects: 3040

Group type: COMPARATOR
Intervention: Placebo (n = 1516)
Number of subjects: 3040
Study: 7970508

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (160 mg/day)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Other hormonal treatments
Number of subjects: 2000
Study: 3276136

Group type: EXPERIMENTAL
Intervention: Lebanese meal (sandwich with unleavened bread and hummos)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Greek meal (lentil stew)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All meals (Indian, Italian, Chinese, Greek, Western, Lebanese)
Number of subjects: 8
Study: 30063618

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 60
Study: 26603917

Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir
Number of subjects: 1236

Group type: COMPARATOR
Intervention: lamivudine
Number of subjects: 1236
Study: 24036842

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus followed by a 2 mg/kg/h infusion until the end of the surgical procedure)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Saline (same volume as lidocaine)
Number of subjects: 51
Study: 22800410

Group type: EXPERIMENTAL
Intervention: STarT Back Tool
Number of subjects: 300

Group type: COMPARATOR
Intervention: Reference standard questionnaires (disability, catastrophizing, fear, and depression)
Number of subjects: 300
Study: 20857058

Group type: EXPERIMENTAL
Intervention: 25 g/day of soy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3 g/day of n‐3 fatty acids (fish oil)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3 g/day of n‐3 fatty acids (fish oil) and 25 g/day of soy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (maintained usual diet)
Number of subjects: 60
Study: 18424064

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 892

Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 892
Study: 15968233

Group type: EXPERIMENTAL
Intervention: Once-daily atomoxetine
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 153
Study: 12855253

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9785713

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 22
Study: 2709169

Group type: EXPERIMENTAL
Intervention: Faculty development course in teaching medical interviewing
Number of subjects: 49
Study: 1264546

Group type: EXPERIMENTAL
Intervention: Daylight phototherapy for 96 hours
Number of subjects: 57

Group type: COMPARATOR
Intervention: No phototherapy (control)
Number of subjects: 57
Study: 29906601

Group type: EXPERIMENTAL
Intervention: SOF (400 mg once daily) + DCV (60 mg once daily)
Number of subjects: 125

Group type: COMPARATOR
Intervention: SOF (400 mg once daily) + SMV (150 mg once daily)
Number of subjects: 125
Study: 26883129

Group type: EXPERIMENTAL
Intervention: Audiovisual supervisor training module
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 81
Study: 25700752

Group type: EXPERIMENTAL
Intervention: GLP-1(7-36) amide at 1.2 pmol/kg/min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study: 23338569

Group type: EXPERIMENTAL
Intervention: Automated ventilation (AV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Protocolized ventilation (PV)
Number of subjects: 60
Study: 21324330

Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (720mg CF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: White chocolate (control)
Number of subjects: 30
Study: 19171828

Group type: EXPERIMENTAL
Intervention: Explorative saccade training (EST) for 6 weeks (digit-search task)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Flicker-stimulation training (FT) for 6 weeks (blind-hemifield stimulation by flickering letters)
Number of subjects: 28
Study: 17709063

Group type: EXPERIMENTAL
Intervention: Semi-standardised acupuncture (12 sessions, at least 6 local and 2 distant points needled per affected knee)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Minimal acupuncture (12 sessions, superficial needling of at least 8 of 10 predefined, bilateral, distant non-acupuncture points)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Waiting list control (2 months no acupuncture)
Number of subjects: 294
Study: 15459835

Group type: EXPERIMENTAL
Intervention: Inhalation of 800 microg salbutamol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 16
Study: 11742431

Group type: EXPERIMENTAL
Intervention: Saquinavir-enhancing therapy (SQV) with stavudine (d4T) and one of ritonavir, nelfinavir, or delavirdine.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (ZDV-associated mutations).
Number of subjects: 31
Study: 9682180

Group type: EXPERIMENTAL
Intervention: 36h continuous sleep deprivation (SD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: nil sleep deprivation (control)
Number of subjects: 20
Study: 7989960

Group type: EXPERIMENTAL
Intervention: HPMC strips containing 40% doxycycline, applied twice a week for 6 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: MC strips containing 40% doxycycline, applied twice a week for 6 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Mechanical debridement (root-planing only)
Number of subjects: 11
Study: 3260659

Group type: EXPERIMENTAL
Intervention: Early coronary bypass surgery
Number of subjects: 767

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 767
Study: 159714

Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride
Number of subjects: 48

Group type: COMPARATOR
Intervention: Zinc sulphate/citrate complex
Number of subjects: 48
Study: 30056612

Group type: EXPERIMENTAL
Intervention: US-TAPb
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no TAPb)
Number of subjects: 100
Study: 28107598

Group type: EXPERIMENTAL
Intervention: Achieving initial abstinence (measured by negative urine screens)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Retention in trials (measured by days retained)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Odds of dropout related to negative urine screens
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Retention time related to negative urine screens
Number of subjects: 440
Study: 25873090

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) with booster sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 0
Study: 23692061

Group type: EXPERIMENTAL
Intervention: PA32540 (EC-ASA 325 mg + IR-omeprazole 40 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Enteric-coated omeprazole 40 mg
Number of subjects: 26
Study: 22260148

Group type: EXPERIMENTAL
Intervention: Self-help manual along with standard care and treatment
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard care and treatment
Number of subjects: 56
Study: 20628129

Group type: EXPERIMENTAL
Intervention: Centralized telecare management by a nurse-physician specialist team with automated home-based symptom monitoring (IVR or Internet)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 405
Study: 17587390

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg daily in week 1, 500 mg twice daily in week 2, 1000 mg twice daily in weeks 3 and 4)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 21
Study: 16138267

Group type: EXPERIMENTAL
Intervention: pioglitazone 45 mg
Number of subjects: 173

Group type: COMPARATOR
Intervention: glimepiride 1-6 mg
Number of subjects: 173
Study: 11895158

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9861542

Group type: EXPERIMENTAL
Intervention: Estradiol (E) infusion (15 ng/kg/hr)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Vehicle infusion
Number of subjects: 19
Study: 8706118

Group type: EXPERIMENTAL
Intervention: 200 mg ibuprofen
Number of subjects: 95

Group type: COMPARATOR
Intervention: 500 mg acetylsalicylic acid
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 2693355

Group type: EXPERIMENTAL
Intervention: Closed reduction and internal fixation with a sliding compression screwplate
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Moore hemiarthroplasty
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Total hip replacement with a Howse semicaptive prosthesis
Number of subjects: 278

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 278
Study: 44669

Group type: EXPERIMENTAL
Intervention: Terbutaline (0.5 microgram)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Terbutaline (2 microgram)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Terbutaline (2 ng - 2 microgram)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no terbutaline)
Number of subjects: 8
Study: 31154431

Group type: EXPERIMENTAL
Intervention: High LV mass-wall stress-heart rate product
Number of subjects: 1522
Study: 30938637

Group type: EXPERIMENTAL
Intervention: 250F-TMPnano dentifrice (250-ppm fluoride plus 0.05% nanosized TMP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 1,100F dentifrice (1,100-ppm fluoride)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 250F dentifrice (250-ppm fluoride)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (without F/TMP)
Number of subjects: 19
Study: 25881623

Group type: EXPERIMENTAL
Intervention: Rapid response hospice at home service
Number of subjects: 953

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 953
Study: 23422946

Group type: EXPERIMENTAL
Intervention: Tropicamide 0.5% before refraction and visual acuity assessment
Number of subjects: 316

Group type: COMPARATOR
Intervention: Tropicamide 0.5% after refraction and visual acuity assessment
Number of subjects: 316
Study: 21067866

Group type: EXPERIMENTAL
Intervention: Changes in estradiol concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testing session during fertile window
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change in estradiol from outside to inside the fertile window
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facial cues of high testosterone
Number of subjects: 0
Study: 19808156

Group type: EXPERIMENTAL
Intervention: Video decision support tool after verbal narrative
Number of subjects: 14

Group type: COMPARATOR
Intervention: Verbal narrative
Number of subjects: 14
Study: 16416218

Group type: EXPERIMENTAL
Intervention: lansoprazole, amoxicillin, and clarithromycin
Number of subjects: 91

Group type: COMPARATOR
Intervention: lansoprazole and placebo
Number of subjects: 91
Study: 15120943

Group type: COMPARATOR
Intervention: Standard arm of uniform treatment, 10% of patients from each participating trial.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upfront randomization and assessment of prognostic profiles.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intent-to-treat evaluation and shared protocol standards.
Number of subjects: 0
Study: 11743703

Group type: EXPERIMENTAL
Intervention: 3D video glasses
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control situation (without video glasses)
Number of subjects: 23
Study: 9260123

Group type: EXPERIMENTAL
Intervention: Donor embryo pregnancies
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard IVF pregnancies
Number of subjects: 67
Study: 8508349

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and cisplatin (FP)
Number of subjects: 295

Group type: COMPARATOR
Intervention: 5-fluorouracil, doxorubicin, and mitomycin C (FAM)
Number of subjects: 295

Group type: COMPARATOR
Intervention: 5-fluorouracil alone (FU)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 295
Study: 2961501

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.32 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.0 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 30318424

Group type: EXPERIMENTAL
Intervention: Buzzy application
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no Buzzy application)
Number of subjects: 65
Study: 27370062

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard Drug Treatment (ST)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Combined Treatment (CBT + ST)
Number of subjects: 46
Study: 24232127

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 5
Study: 22509402

Group type: EXPERIMENTAL
Intervention: Genotype-based NRT dosing
Number of subjects: 633

Group type: COMPARATOR
Intervention: Phenotype-based NRT dosing
Number of subjects: 633
Study: 20302678

Group type: EXPERIMENTAL
Intervention: Online GAD intervention (E-couch) with human support (telephone calls)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online GAD intervention (E-couch) with automated support (emails)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-active intervention arms
Number of subjects: 0
Study: 18593081

Group type: EXPERIMENTAL
Intervention: Hypertonic saline nasal irrigation (HSNI)
Number of subjects: 28
Study: 16222065

Group type: EXPERIMENTAL
Intervention: Obese patients
Number of subjects: 509

Group type: COMPARATOR
Intervention: Non-obese patients
Number of subjects: 509
Study: 12393308

Group type: EXPERIMENTAL
Intervention: Imipramine (TCA)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (SSRI)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Unmedicated patients
Number of subjects: 52
Study: 10432886

Group type: EXPERIMENTAL
Intervention: Induced sputum collection
Number of subjects: 107

Group type: COMPARATOR
Intervention: Sputum collected at home
Number of subjects: 107
Study: 7480228

Group type: EXPERIMENTAL
Intervention: Textured devices irrigated with Betadine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Smooth devices irrigated with saline solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Betadine-irrigated devices
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Textured-surface devices
Number of subjects: 60
Study: 1705432

Group type: EXPERIMENTAL
Intervention: Cerulein at doses of 0.05, 0.1, 0.2, 0.3, 0.5 microgram/Kg/h
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline solution (125 ml/h)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cerulein (various doses)
Number of subjects: 25
Study: 7211531

Group type: EXPERIMENTAL
Intervention: Contingent reinforcement for morphine-free urinalysis results
Number of subjects: 7

Group type: COMPARATOR
Intervention: Non-reinforcement weeks
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Post-study period
Number of subjects: 7
Study: 31892662

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (two oral boluses of 100,000 IU vitamin D3 with 400 IU vitamin D3 daily)
Number of subjects: 865

Group type: COMPARATOR
Intervention: Placebo (identical placebo boluses with daily placebo)
Number of subjects: 865

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 865

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 865
Study: 28698999

Group type: EXPERIMENTAL
Intervention: Web-based tailored intervention (Cancer Aftercare Guide)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 462
Study: 26012120

Group type: EXPERIMENTAL
Intervention: Superelastic NiTi archwires
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Heat activated NiTi archwires
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 189
Study: 24456624

Group type: EXPERIMENTAL
Intervention: Arm A: 25μg/inoculation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Arm B: 100μg/inoculation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Arm C: Control group (no injections)
Number of subjects: 24
Study: 22704461

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 220 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 150 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0
Study: 19854395

Group type: EXPERIMENTAL
Intervention: RCTs published in CONSORT-endorsing journals
Number of subjects: 42

Group type: COMPARATOR
Intervention: RCTs published in nonendorsing journals
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Generic methodologic criteria reporting
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Adverse-event-related criteria reporting
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Specific nonpharmacologic criteria reporting
Number of subjects: 42
Study: 15834756

Group type: EXPERIMENTAL
Intervention: GLV with more oil (100 g GLV/day + 5 g oil/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GLV with vitamin E (100 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Beta-carotene without GLV (10 mg/day)
Number of subjects: 40
Study: 12504142

Group type: EXPERIMENTAL
Intervention: Test option 200 N and 0.15 m/s
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Test option 200 N and 0.30 m/s
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Transitional friction measurement
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Minimum friction coefficient
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Limit for preventing a slip
Number of subjects: 8
Study: 11593611

Group type: EXPERIMENTAL
Intervention: Transfusion of fresh whole blood
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Traditional herb medicines
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Dynamic observation of hemorrheologic changes
Number of subjects: 238
Study: 8532025

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of epoprostenol
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 81
Study: 1676368

Group type: EXPERIMENTAL
Intervention: 5 mg/day tertatolol (T)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 80 mg/day nadolol (N)
Number of subjects: 0